<DOC>
	<DOCNO>NCT00534196</DOCNO>
	<brief_summary>RATIONALE : Implant radiation therapy delivers high dose radiation directly tumor may kill tumor cell cause less damage normal tissue . PURPOSE : This clinical trial study side effect well implant radiation therapy use radioactive iodine work treat patient localized prostate cancer .</brief_summary>
	<brief_title>Implant Radiation Therapy Using Radioactive Iodine Treating Patients With Localized Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine efficacy permanent brachytherapy iodine I 125 seed patient localized prostate cancer . - To determine safety therapy patient . OUTLINE : This multicenter study . Patients undergo permanent brachytherapy seed implantation comprise iodine I 125 prostate . Some patient may receive combination treatment ( e.g. , external beam radiation therapy ( EBRT ) hormone therapy addition brachytherapy ) . Quality life International Prostate Symptom Score ( IPSS ) assess compare .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>Cadexomer iodine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinically histologically confirm localized prostate cancer PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : No prior concurrent surgery No prior concurrent radiotherapy Prior chemotherapy , hormonal therapy , biologic therapy allow</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
</DOC>